Clinical Trials Directory

Trials / Unknown

UnknownNCT02180126

Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic Inflammation

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A positive Anti-Neutrophil Cytoplasm Antibody (ANCA) test administered to patients with a high probability for vasculitis has high sensitivity and specificity for vasculitis. A positive ANCA test result in those patients who do not have a high probability for vasculitis requires extensive follow-up because those patients eventually present with malignancy or other inflammatory diseases. The investigators wish to investigate the correlation between the differing levels of positive ANCA tests and their relationship to vasculitis, malignancy and inflammatory diseases.

Conditions

Interventions

TypeNameDescription
OTHERFollow-upFollow-up of of patients with borderline positive ANCA test results

Timeline

Start date
2014-08-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2014-07-02
Last updated
2014-07-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02180126. Inclusion in this directory is not an endorsement.